Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Unknown 2Recruiting 1

Sponsor Class

OTHER 89NIH 20OTHER_GOV 3INDUSTRY 2

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1Breast 1

Conditions

Stomach Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Breast Neoplasms 1

Interventions

Cisplatin 50Capecitabine 42apatinib 34Radiotherapy 33Oxaliplatin 33Gemcitabine 33Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 21Nivolumab 19pembrolizumab 18fludarabine 18Radiation 16Metformin 16Exercise 16camrelizumab 15S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Tomography, X-Ray Computed × Clear all
NCT04740346 2021-10-27

Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP)

National Cancer Center, Korea

Phase NA Recruiting
886 enrolled
Gastrointestinal

Recurrence, Stomach Neoplasms

NCT03266744 2017-08-30

RESPECT

East and North Hertfordshire NHS Trust

Phase NA Unknown
40 enrolled
Breast

Breast Neoplasms

NCT02738346 2016-04-25

CBPC

University Hospital, Angers

Phase 3 Unknown
164 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡